Aardvark Therapeutics, Inc.
AARD
$8.22
-$0.30-3.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.59M | -13.85M | -11.78M | -9.49M | -7.21M |
| Total Depreciation and Amortization | 16.00K | 65.00K | 4.00K | 2.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 912.00K | 817.00K | 1.40M | 1.43M | 1.47M |
| Change in Net Operating Assets | 1.57M | 1.45M | 1.23M | 575.50K | -81.00K |
| Cash from Operations | -18.09M | -11.52M | -9.15M | -7.49M | -5.82M |
| Capital Expenditure | -109.00K | -103.00K | -98.00K | -49.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.89M | -- | -- | -- | -- |
| Cash from Investing | -12.00M | -103.00K | -98.00K | -49.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 332.00K | 169.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 85.00M | 85.00M | 85.00M | 42.50M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.34M | -2.16M | -2.06M | -1.03M | -- |
| Cash from Financing | 81.99M | 83.01M | 82.94M | 41.47M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.91M | 71.39M | 73.70M | 33.94M | -5.82M |